Obsidian Presents Preclinical Data at ASGCT Showing Advancement of Its Regulated IL12 and IL15 Programs to … – Business Wire (press release)
Business Wire (press release) |
Obsidian Presents Preclinical Data at ASGCT Showing Advancement of Its Regulated IL12 and IL15 Programs to …
Business Wire (press release) “IL12 and IL15 are critical factors that promote CAR–T cell expansion, persistence, and penetration into solid tumors,” said Vipin Suri, Ph.D., Vice President of Discovery of Obsidian. “However, unregulated expression of these cytokines by CAR-T or … |
